News Focus
News Focus
Followers 50
Posts 9237
Boards Moderated 0
Alias Born 01/13/2007

Re: None

Monday, 04/20/2020 5:56:08 PM

Monday, April 20, 2020 5:56:08 PM

Post# of 21574
Looks like we're onto something with the institutional buying. Looks like Acorn Financial bought 250k in the first quarter. https://fintel.io/so/us/ntrp

I looked on their website and noticed this section in particular.

"Business
Sales & Mergers
Acorn Financial is uniquely positioned to help assist and advise business owners in evaluating the sale of a business or the prospects of a successful merger. Our Advisors have diverse educational and professional backgrounds that qualify them to work closely alongside top legal professionals to analyze, structure, and complete the sale or merger of your business"
https://acorn-financial.com/services-offered/

I still can't help but wonder if we eventually join up with Bryologyx. There was a blockbuster study published by Nature today detailing progress in synthetic bryostatin especially regarding CAR T cancer treatments. https://www.nature.com/articles/s41467-020-15742-7

BryX would own that IP yet Alkon is working with the NCI on the pediatric cancer study. BryX also picked up the autoimmune conditions IP that includes the incredible Crohn's study from last summer. Plus their co founder started Neurotrope. Wishful thinking maybe, but moving forward would open multiple opportunities as we await further AD developments Imo.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News